IDH1 and acute myeloid leukemia: Finally, leukemic cells display a higher level of anabolic intermediates, such as the pentose phosphate pathway (PPP) and the citric acid cycle (CAC) [10], while 20% of AML patients present mutations in the IDH genes, which affect mitochondrial metabolism and is associated with poor prognoses [26].